366 studies found for:    metabolic syndrome AND syndrome X AND insulin resistance AND diabetes
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
21 Unknown  Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)
Conditions: Metabolic Syndrome;   Diabetes
Intervention:
22 Unknown  Frequency of Metabolic Syndrome in Down Syndrome Patients
Conditions: Metabolic Syndrome X;   Down Syndrome
Intervention:
23 Completed Effect of Increased Intake of Low Fat Dairy Products on Weight Loss and Insulin Resistance
Conditions: Impaired Glucose Tolerance;   Type 2 Diabetes;   Metabolic Syndrome
Interventions: Behavioral: High dairy and calcium intake;   Behavioral: Usual intake
24 Active, not recruiting Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
Conditions: Metabolic Syndrome X;   Overweight;   Hypertension;   Dyslipidemias;   Prediabetic State
Interventions: Drug: Placebo Comparator Limb 1;   Drug: Chloroquine
25 Active, not recruiting LUPS-Lipids and Glucose Under Prospective Surveillance
Conditions: Metabolic Syndrome, Syndrome X, MetS,;   Diabetes Mellitus, Non-Insulin-Dependent
Intervention:
26 Unknown  Metabolic Syndrome and Insulin Resistance at Allina
Condition: Metabolic Syndrome
Intervention: Dietary Supplement: vitamin D3 (cholecalciferol)
27 Completed Probiotic Bacteria in Prevention of the Metabolic Syndrome
Condition: Metabolic Syndrome X
Interventions: Dietary Supplement: Lactobacillus plantarum PCS 26;   Dietary Supplement: Placebo
28 Recruiting Resveratrol and the Metabolic Syndrome
Conditions: Obesity;   Insulin Resistance;   Metabolic Syndrome
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Resveratrol
29 Unknown  The Roles of Cytokines in the Mechanism of Insulin Resistance and Energy Balance
Conditions: Metabolic Syndrome X;   Cachexia;   Insulin Resistance
Intervention:
30 Recruiting Weight Loss Program to Prevent Heart Disease
Conditions: Insulin Resistance,;   Metabolic Syndrome;   Type 2 Diabetes
Intervention: Behavioral: PilAm Go4Health Weight-loss Program
31 Recruiting Metformin in the Diastolic Dysfunction of Metabolic Syndrome
Conditions: Metabolic Syndrome X;   Diastolic Dysfunction;   Insulin Resistance
Interventions: Behavioral: Lifestyle Counseling;   Drug: Metformin
32 Completed Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion
Conditions: Insulin Resistance Syndrome X;   Pancreatic Beta Cell Function
Intervention: Drug: N-acetylcysteine, intralipid, heparin
33 Unknown  Side Effects of Antipsychotic Medications
Conditions: Insulin Resistance;   Metabolic Syndrome X;   Schizophrenia and Disorders With Psychotic Features;   Mood Disorders;   Psychotic Disorders
Intervention:
34 Completed Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Baker’s yeast (Bio Chromium)
35 Completed A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes
Conditions: Diabetes Mellitus, Type 2;   Metabolic Syndrome X
Interventions: Drug: NC-503 (eprodisate disodium);   Other: placebo
36 Active, not recruiting Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes
Conditions: Diabetes;   Metabolic Syndrome;   Insulin Resistance
Intervention: Drug: pegvisomant
37 Completed Integrating Lifestyle Therapy for Diabetes Prevention Into Primary Care
Conditions: Pre-Diabetes;   Metabolic Syndrome;   Type 2 Diabetes
Intervention: Behavioral: Lifestyle intervention and provider feedback
38 Completed Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 Diabetes
Condition: Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: Rosiglitazone
39 Completed Efficacy of a Prebiotic Galactooligosaccharide to Reduce Metabolic Syndrome Risk Factors in Overweight Adults
Condition: Metabolic Syndrome X
Interventions: Dietary Supplement: Bimuno;   Dietary Supplement: Maltodextrin
40 Completed Functional MRI Biomarkers of Cognitive Decrements in Diabetes
Conditions: Diabetes Mellitus, Type 2;   Metabolic Syndrome X;   Mild Cognitive Impairment
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years